Asbestos have been used in many different environments, including industrial and home construction projects, vehicles, railroads and shipyards, to name a few. Asbestos have significantly affected many lives, particularly individuals and their families who have experienced substantial direct or indirect occupational exposure to asbestos as well as asbestos-containing products and equipment. Many diseases and conditions are reported to have a direct or indirect causal link to asbestos exposure. This book summarises the historical background, current knowledge and advancements concerning asbestos and its related diseases in a simple, easy to understand and concise format. The first chapter covers asbestos mineralogy, industrial applications, occupational and environmental exposure as well as methods of fiber analysis. The second chapter focuses on asbestos pathogenesis, including asbestos levels in the environment and various worksites, the biological effects of asbestos fibers and factors determining its toxicity. The third chapter provides an overview of asbestos-related diseases such as asbestosis, pleural diseases, lung cancer and mesothelioma. Each section also includes a discussion of cause and causation, clinical presentation, pathology, diagnosis, treatment, prognosis and surveillance. The fourth chapter outlines the basic concepts of biostatistics and epidemiology, criteria in establishing the causal relationships, the occupational approach of environmental diseases and current standards and regulations. This book serves as an easy to read, quick reference presented in a bulleted format that allows readers to quickly and easily review the information. It is a useful resource for occupational medicine specialists, healthcare providers and environmental scientists who are interested in understanding asbestos and managing asbestos-related diseases.

Asbestos is the commercial name for various mineral silicates associated with numerous respiratory diseases, notably mesothelioma, asbestosis and lung cancer. This book examines risk assessments, health implications and impacts on the environment of asbestos. Chapter One provides a summary of exposure during abatement/removal of asbestos-containing floor tile and mastic. Chapter Two discusses the epidemiological patterns of environmental asbestos-related disease. Chapter Three reviews the reduction of anti-tumor immunity caused by asbestos exposure. Chapter Four summarises current knowledge about the putative role of asbestos exposure in intrahepatic cholangiocarcinoma carcinogenesis. Chapter Five determines the impact of malignant mesothelioma (MM) using average life years lost and lifetime healthcare expenditures in Taiwan. Chapter Six reviews recent perspectives on both asbestos-related pleuritis and anti-neutrophil cytoplasmic antibody (ANCA)-related vasculitides. Chapter Seven clarifies subjects for protective policies against asbestos disaster and the meanings of local government asbestos measures in the case of Japan. Chapter Eight includes an overview of the mineralogical and morphological characterisation of asbestos in Argentina.

Much of the more than 30 million tons of asbestos used in the United States since 1900 is still present as insulation in offices and schools, as vinyl-asbestos flooring in homes, and in other common products. This volume presents a comprehensive evaluation of the relation of these fibers to specific diseases and the extent of nonoccupational risks associated with them. It covers sources of asbestiform fibers, properties of the fibers, and carcinogenic and fibrogenic risks they pose.

With an emphasis on practical diagnostic problem solving, Pathology of the Lungs, 3rd Edition provides the pulmonary pathologist and the general surgical pathologist with an accessible, comprehensive guide to the recognition and interpretation of common and rare neoplastic and non-neoplastic lung conditions. The text is written by two authors and covers all topics in a consistent manner without the redundancies or lapses that are common in multi-authored texts. The text is lavishly illustrated with the highest quality illustrations which accurately depict the histologic, immunohistochemical and cytologic findings under consideration and it is supplemented throughout with practical tips and advice from two internationally respected experts. The user-friendly design and format allows rapid access to essential information and the incorporation throughout of relevant clinical and radiographic information makes it a complete diagnostic resource inside the reporting room. Approximately 1,000 high quality full color illustrations.Provides the user with a complete visual guide to each specimen and assists in the recognition and diagnosis of any slide looked at under the microscope. Comprehensive coverage of both common and rare lung diseases and disorders. One stop consultation resource for the reporting room or study, no need to go further to get questions answered. Clinical background and ancillary radiographs incorporated throughout.Provides the user with all of the necessary diagnostic tools to make a complete and accurate pathologic report. Practical advice and tips from two of the world’s recognized experts. Provides the trainee and general surgical pathologist with time saving diagnostic clues when dealing with difficult specimens. Consistent and uniform approach incorporated for each disease and disorder (Etiology, pathogenesis, clinical features, pathologic features, differential diagnosis) User-friendly format enables quick and easy navigation to the key information required. Extensive use of summary tables, charts and graphs throughout the text. Helps simplify and clarify complex concepts and facilitates “at a glance comparisons between entities. Extensive reference list highlights landmark articles as well as including most up-to-date citations. Directs the trainee and practitioner to the most recent and authoritative sources for further reading and investigation

The United States is among the wealthiest nations in the world, but it is far from the healthiest. Although life expectancy and survival rates in the United States have improved dramatically over the past century, Americans live shorter lives and experience more injuries and illnesses than people in other high-income countries. The U.S. health disadvantage cannot be attributed solely to the adverse health status of racial or ethnic minorities or poor people: even highly advantaged Americans are in worse health than their counterparts in other, "peer" countries. In light of the new and growing evidence about the U.S. health disadvantage, the National Institutes of Health asked the National Research Council (NRC) and the Institute of Medicine (IOM) to convene a panel of experts to study the issue. The Panel on Understanding Cross-National Health Differences Among High-Income Countries examined whether the U.S. health disadvantage exists across the life span, considered potential explanations, and assessed the larger implications of the findings. U.S. Health in International Perspective presents detailed evidence on the issue, explores the possible explanations for the shorter and less healthy lives of Americans than those of people in comparable countries, and recommends actions by both government and nongovernment agencies and organizations to address the U.S. health disadvantage.

Provides guidance on controlling asbestos-containing materials (ACM) found in buildings. Provides a current summary of data on exposure to airborne asbestos; gives survey procedures for determining if ACM is present in buildings; explains how to establish a special operations and maintenance program in a building found to contain asbestos; reviews technical issues confronted when assessing the potential for exposure to airborne asbestos, in particular indoor settings; suggests a structured process for selecting a particular course of action, and much more. Commonly referred to as the Blue Book.